N@N

CELGZ, AGG, ALIM, LQD, HPJ, ALN Are Seasonally Ripe To Go Down In the Next Five Weeks

February 27, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Celgene Corporation (NASDAQ:CELGZ), iShares Barclays Aggregate Bond (NYSE:AGG), Alimera Sciences Inc. (NASDAQ:ALIM), iShares iBoxx $ InvesTop Investment Grade Corporate Bond Fund (NYSE:LQD), Hong Kong Highpower Technology (NASDAQ:HPJ), American Lorain Corp (NYSE:ALN) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  CELGZ   Celgene Corporation              -5.86%           100.00% (6 of 6)     Tuesday, April 11th 2017
  AGG     iShares Barclays Aggregate Bond  -0.48%           100.00% (13 of 13)   Thursday, March 2nd 2017
  ALIM    Alimera Sciences Inc.            -8.61%           100.00% (6 of 6)     Tuesday, April 11th 2017
  LQD     iShares iBoxx $ InvesTop Investment Grade Corporate Bond Fund  -0.73%           85.71% (12 of 14)    Thursday, March 2nd 2017
  HPJ     Hong Kong Highpower Technology   -7.66%           100.00% (8 of 8)     Thursday, March 9th 2017
  ALN     American Lorain Corp             -7.16%           87.50% (7 of 8)      Monday, April 3rd 2017

Celgene Corporation (NASDAQ:CELGZ) - Celgene Corporation discovers, develops, and commercializes innovative therapies to treat cancer and immune-inflammatory diseases in the United States, Europe, and internationally. Its commercial stage products include REVLIMID for the treatment in combination with dexamethasone for multiple myeloma patients, as well as patients with transfusion-dependent anemia; and THALOMID to treat, in combination with dexamethasone, patients with newly diagnosed multiple myeloma, as well as for the prevention and suppression of cutaneous manifestations of erythema nodosum leprosum recurrence. The company also sells VIDAZA, used to subtypes of myelodysplastic syndromes; RITALIN to treat attention deficit hyperactivity disorder; FOCALIN to prevent oncology-related disorders; and ALKERAN to treat multiple myeloma and carcinoma of the ovary. Its development stage products consist of CC-4047, which is in Phase I and Phase II clinical trials for treating disease indications, including sickle cell anemia, myelofibrosis, and multiple myeloma; CC-10004, a Phase II clinical trial product for psoriasis and psoriatic arthritis; CC-11050, a Phase I clinical trial completed product for inflammatory conditions; CC-401, a Phase I clinical trial completed product to identify kinases that regulate pathways critical in inflammation and oncology; CC-930, a Phase Ib clinicial trial completed product for fibrotic conditions; and Amrubicin, a Phase III clinical trial product for small cell lung cancer treatment. In addition, the company is researching stem cells derived from the human placenta, as well as from the umbilical cord. Celgene Corporation has strategic collaborations with Acceleron Pharma, Inc. and Agios Pharmaceuticals Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey..

iShares Barclays Aggregate Bond (NYSE:AGG) - ISHARES LEH AGG F.

Alimera Sciences Inc. (NASDAQ:ALIM) - Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, Portugal, and the United Kingdom. The company focuses on diseases affecting the back of the eye or retina. The company offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. Its ILUVIEN is inserted in the back of the patient s eye in a non-surgical procedure, which allows for a self-sealing wound by delivering a constant micro-dose of the non-proprietary corticosteroid fluocinolone acetonide in the eye. It has license agreement with pSivida US, Inc. for the development and sale of ILUVIEN, and a delivery device to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans (other than uveitis) or to treat DME. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia..

iShares iBoxx $ InvesTop Investment Grade Corporate Bond Fund (NYSE:LQD) - ISHARES GS INVESTOP.

Hong Kong Highpower Technology (NASDAQ:HPJ) - Highpower International, Inc., through its subsidiaries, manufactures and trades in nickel metal hydride rechargeable batteries for consumer and industrial applications. It produces consumer batteries in A, AA, and AAA sizes in blister packing, as well as chargers and battery packs; and industrial batteries, which are designed for electric bikes, power tools, and electric toys. The company also manufactures lithium-ion and lithium polymer rechargeable batteries for applications in laptops, digital cameras, and wireless communication products. In addition, it recycles scrap battery materials and resells the recycled materials; engages in processing and marketing, and research of battery materials; and designs and produces battery packs and systems. The company sells its products to original equipment manufacturers, and distributors and resellers. The company was formerly known as Hong Kong Highpower Technology, Inc. and changed its name to Highpower International, Inc. in October 2010. Highpower International, Inc. was founded in 2001 and is headquartered in Shenzhen, the People s Republic of China..

American Lorain Corp (NYSE:ALN) - American Lorain Corporation, through its subsidiaries, develops, manufactures, and sells various food products in the People s Republic of China. It offers chestnut products, including frozen chestnuts and aerated open-bottom chestnuts; and frozen food products, such as frozen vegetables and frozen fruits The company also provides convenience foods comprising ready-to-cook food products, ready-to-eat food products, and meals ready-to- eat products consisting of meal kits with self-heating devices or microwavable kits, such as microwavable rice boxes for military use, as well as for camping, traveling, and other occasions. The company markets and sells its products to supermarket chains, mass merchandisers, wholesalers, and others, as well as to third-party distributors. It also exports its products to the Asia Pacific, Europe, the Middle East, and North America. The company was formerly known as Millennium Quest, Inc. American Lorain Corporation is headquartered in Junan County, the People s Republic of China..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---